Millions of adults worldwide are diagnosed with Attention Deficit Hyperactivity Disorder (ADHD) each year. However, a new study reveals serious methodological flaws in many studies on adult ADHD, including those on treatment.
These flaws make it difficult for doctors and patients to rely on research findings in actual clinical practice. This study was conducted jointly by researchers from the University of Copenhagen and the University of São Paulo, Brazil.
ADHD was initially defined as a childhood disorder. This means that its diagnostic criteria are based on children’s behavioral manifestations, such as hyperactivity and impulsivity. Diagnosing adult ADHD is more complex. Doctors often need to rely on patients’ self-reports, such as difficulty concentrating, restlessness, or impulsive behavior. These subjective reports can vary considerably and are less reliable than assessments of children’s behavior.
One of the study’s authors, Dr. Igor Studart, explained, “The increasing number of adults being diagnosed with Attention Deficit Hyperactivity Disorder (ADHD) raises serious questions about the validity of these diagnoses. Many adults were never diagnosed in childhood. Some seek help only after encountering ADHD-related content on social media. This makes us wonder how randomized controlled trials for ADHD treatment address these diagnostic challenges.”
Another challenge is that ADHD symptoms often overlap with other mental health conditions, including depression, schizophrenia, and bipolar disorder. Accurate diagnosis requires careful evaluation by an experienced psychologist or psychiatrist. This new study found that many clinical trials for ADHD treatment have not consistently conducted such comprehensive evaluations. Therefore, participants in these studies may have had undiagnosed conditions, affecting the results.
The researchers emphasize that these shortcomings limit the practicality of current research on ADHD treatment in adults. They call for more stringent diagnostic criteria in clinical research, including comprehensive evaluations to exclude other mental disorders. Without these measures, research may overestimate or misunderstand the effectiveness of ADHD treatment in adults.
The findings highlight the urgent need for better-designed clinical trials to provide reliable guidance for healthcare providers. Adults seeking treatment for ADHD deserve evidence-based therapies grounded in rigorous and accurate research.
